Main Article Content

Anel Gomez Garcia http://orcid.org/0000-0002-9158-1095 Veronica Haydee Montero Guzman Cleto Alvarez Aguilar


Introduction. High blood pressure (HBP) in children and adolescents are often an entity underdiagnosed. An increase in cardiovascular risk factors (CVRF) has been recently reported in adolescents. The objective of this study was to evaluate the frequency of hypertension and pre-hypertension and the risk factors associated to hypertension in Mexican adolescents.

Methods. Cross-sectional study was realized in adolescents, both genders between 15 and 19 years of age. Clinical variables age, sex, weight, height, body mass index, blood pressure, family history of diabetes and hypertension,  weeks of gestation at birth were obtained and blood samples were collected for measurement of cholesterol, triglycerides, low density lipoprotein, very low density lipoproteins, high density lipoproteins, uric acid and serum insulin. Data were analyzed in SPSS version 18.0.

Results. 384 adolescents between 15 and 18 years old were studied. Of those studied, 291 (75.8%) are female and 93 (24.2%) male. Hypertension was found in a 6% of all adolescents, Pre-Hypertension in 9.4% and normal BP in 84.6%. The relationships between systolic blood pressure and glucose (r= 0.170; P= 0.001), TCh (r= 0.119; P= 0.020), HDL (r= -0.147; P= 0.004) y LDL (r= 0.166; P= 0.001) were realized. Male sex (RR:3.97; 95%CI:2.51-6.27), family history of hypertension (RR:3.81; 95%CI:2.39-6.05) and obesity (RR:3.29; 95%CI:2.11-5.15) were risk factors involved in the development of hypertension.

Conclusions. We found a 6% of frequency of hypertension and 9% of Pre-hypertension. Male sex and family history of hypertension were the risk factors more associated for hypertension in adolescents. It is necessary to realize longitudinal studies with a specific methodology and laboratory studies for analyzing the impact of traditional risk factors in the development of cardiovascular disease in adolescents.

Article Details

How to Cite
GOMEZ GARCIA, Anel; MONTERO GUZMAN, Veronica Haydee; ALVAREZ AGUILAR, Cleto. RISK FACTORS ASSOCIATED WITH HYPERTENSION IN MEXICAN ADOLESCENTS.. Medical Research Archives, [S.l.], v. 4, n. 5, sep. 2016. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/616>. Date accessed: 16 july 2024.
Risk factors, Hypertension, adolescents.
Research Articles


1. de la Cerda Ojeda F, Herrero Hernando C. (2014). Hipertensión arterial en niños y adolescentes. Hipertensión arterial en niños y adolescentes. Protoc Diagn Ter Pediatr, 1:171-89.

2. Martínez-Gómez D, Eisenmann JC, Gómez-Martínez S, Veses M, Marcos A, Veiga OL. (2010). Sedentarismo, adiposidad y faqctores de riesgo cardiovascular en adolescents. Estudio AFINOS. Rev Esp Cardiol, 63(3):277-285.

3. Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. (2005). Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med Clin (Barc), 124(16):606-612.

4. Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, et al. (1998). Saad MF, Selby J, Hamman RF, Krauss RM, Haffner SM. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism, 47:1174-1179.

5. Rocchini AP. (2002). Childhood obesity and diabetes epidemic. N Engl J Med, 346:854-855.

6. Dietz WH. (1998). Health consequences of obesity in youth: Childhood predictors of adult disease. Pediatrics, 101 suppl:518-524.

7. Rey-López JP, Vicente-Rodríguez G, Biosca M, Moreno LA. (2008). Sedentary behaviour and obesity development in children and adolescents. Nutr Metabol Cardiovasc Dis, 18:242-251.

8. Rodríguez Morán M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. (2004). Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care, 27:2516-2517.

9. James PA, Oparil S, Carter BL, Cushman WC, Dennison HC, Handler J, et al. (2014). Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5):507-520.

10. Ostchega Y, Carroll M, Prineas RJ, McDowell MA, Louis T, TillertT. (2009). Trends of elevated blood pressure among children and adolescents: data from the National Health and Nutrition Examination Survey 1998-2006. Am J Hypertens, 22(1):59-67.

11. Ferrer Arrocha M, Rodríguez Fernández C, González Pedroso MT, Díaz Dehesa MB, Núñez García M. (2009). Obesidad, hipertensión y tabaquismo:: señales ateroscleróticas tempranas en adolescentes de la secundaria básica "Guido Fuentes". Rev Cubana Invest Bioméd [Internet]. Jun [citado 2016 Ago 09]; 28(2): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002009000200006&lng=es.

12. Salazar Vázquez B, Rodríguez morán M, Guerrero Romero F. (2005). Factores bioquímicos asociados a riesgo cardiovascular en niños y adolescentes. Rev Med IMSS, 43(4):299-303.

13. Rocella J. (2004). The Fourth Report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics, 114(3):555-76.

14. Abraham W, Blanco G, Coloma G, Cristaldi A, Gutiérrez N, Sureda L, SAHA. ERICA Estudio de los Factores de Riesgo Cardiovascular en Adolescents. Rev Fed Arg Cardiol. 2013; 42(1):29-34.

15. Arjona Ortejón N, Chávez Delgado S, Romero JJ. (2002). Prevalencia y factores asociados a las dislipidemias en niños(as) y adolescentes de Costa Rica. http://revistasan.ucr.ac.cr/san/index.php/revistasan/article/iew/26.

16. Kavey RE. (2015). Combined dyslipidemia in childhood. J Clin Lipidol, 9(5 Suppl):S41-56. DOI:10.1016/j.jacl.2015.06.008.

17. Frontini MG, Srinivasan SR, Xu J, Bond MG, Berenson GS. (2008). Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in: the Bogalusa Heart Study Maria G. Pediatrics, 121; 924–929.

18. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. (1999). The relation of overweight to cardiovascular risks factors among children: the Bogalusa Heart Study. Pediatrics, 123(3):750-757.

19. Lambert M, Delvin EE, Levy E, O’Loughlin J, Paradis G, Barnett T, et al. (2008). Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol, 24(7):575-583.

20. Gómez-García A, Rangel-García L, Alvarez Aguilar C. (2012). Estudio transversal para evaluar el riesgo cardiovascular en los hijos de padres con diabetes mellitus o hipertensión arterial. Semergen, 38(5):278-284.

21. Whitaker RC, Wright JA, Pepe MS. (1997). Predicting Obesity in young adulthood from childhood and parental obesity. N Engl J Med, 337:869-873.

22. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. (2011). Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics, 128(Suppl 5):S213-56.

23. Cohen E, Kip KE, Marroquin OC, Kiesau M, Hipps L, Peters RE, et al. (2006). Screening children to identify families at increased risk for cardiovascular Disease. Pediatrics, 118: e1789---97.

24. Lee KE, Klein BE, Klein R. (2003). Familial aggregation of components of the multiple metabolic syndrome in the Framingham heart and offspring cohorts: genetic analysis workshop problem 1. BMC Genet, 4 Suppl 1:S94.

25. McCrindle BW, Kwiterovich PO, McBride PE, Daniels SR, Kavey RE. (2012). Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics, 130:353-6.

26. Gomez García A, García Núñez G, Viveros Sandoval ME, Gutierrez Castellanos S, Alvarez Aguilar C. (2014). Factors associated with early platelet activation in obese children. Clinical Medicine & Research, 12(1-2):21-26.

27. Hong YM. (2010). Atherosclerotic cardiovascular disease beginning in childhood. Korean Circ J, 40:1–9.

28. Valle Jiménez M, Martos Estepa R, Morales Camacho RM, Cañete Estrada R, Gascón Luna F, Bermudo Guitarte F. (2007). Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. European J Endocrinol, 156:497–502.